ERGOLINE DERIVATIVES
The present invention provides novel bicyclic ergoline esters useful as serotonin antagonists. These esters are of the general formula (I): (I) wherein: R is a primary or secondary C1-C8 alkyl group, -CH2-C2-C4 alkenyl, C3-C8 cycloalkyl, or C3-C8 cycloalkyl substituted with one or more primary or se...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
02.06.1992
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides novel bicyclic ergoline esters useful as serotonin antagonists. These esters are of the general formula (I): (I) wherein: R is a primary or secondary C1-C8 alkyl group, -CH2-C2-C4 alkenyl, C3-C8 cycloalkyl, or C3-C8 cycloalkyl substituted with one or more primary or secondary C1-C5 alkyl groups, with the proviso that the total number of carbon atoms in R does not exceed 8; R1 is Cl-C4 alkyl; R2 is ; R3 is hydroxy, C1-C4 alkoxy, halo, C1-C4 alkyl or -?-R4; R4 is hydroxy, C1-C4 alkoxy or amino; m is 3, 4 or 5; n is 2, 3, 4 or 5; p is 0, 1, 2, or 3; or a pharmaceutically acceptable salt thereof. |
---|---|
AbstractList | The present invention provides novel bicyclic ergoline esters useful as serotonin antagonists. These esters are of the general formula (I): (I) wherein: R is a primary or secondary C1-C8 alkyl group, -CH2-C2-C4 alkenyl, C3-C8 cycloalkyl, or C3-C8 cycloalkyl substituted with one or more primary or secondary C1-C5 alkyl groups, with the proviso that the total number of carbon atoms in R does not exceed 8; R1 is Cl-C4 alkyl; R2 is ; R3 is hydroxy, C1-C4 alkoxy, halo, C1-C4 alkyl or -?-R4; R4 is hydroxy, C1-C4 alkoxy or amino; m is 3, 4 or 5; n is 2, 3, 4 or 5; p is 0, 1, 2, or 3; or a pharmaceutically acceptable salt thereof. |
Author | GARBRECHT, WILLIAM L FLUDZINSKI, PAWEL MARZONI, GIFFORD P |
Author_xml | – fullname: FLUDZINSKI, PAWEL – fullname: GARBRECHT, WILLIAM L – fullname: MARZONI, GIFFORD P |
BookMark | eNrjYmDJy89L5WQQcQ1y9_fx9HNVcHEN8gxzDPEMcw3mYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxzo6GxgZGJgamzsaEVQAAynkfeA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | DERIVES ERGOLINE |
Edition | 5 |
ExternalDocumentID | CA1302405C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA1302405C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:26:02 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA1302405C3 |
Notes | Application Number: CA19880566319 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19920602&DB=EPODOC&CC=CA&NR=1302405C |
ParticipantIDs | epo_espacenet_CA1302405C |
PublicationCentury | 1900 |
PublicationDate | 19920602 |
PublicationDateYYYYMMDD | 1992-06-02 |
PublicationDate_xml | – month: 06 year: 1992 text: 19920602 day: 02 |
PublicationDecade | 1990 |
PublicationYear | 1992 |
RelatedCompanies | ELI LILLY AND COMPANY |
RelatedCompanies_xml | – name: ELI LILLY AND COMPANY |
Score | 2.420106 |
Snippet | The present invention provides novel bicyclic ergoline esters useful as serotonin antagonists. These esters are of the general formula (I): (I) wherein: R is a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | ERGOLINE DERIVATIVES |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19920602&DB=EPODOC&locale=&CC=CA&NR=1302405C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOpNQYO_OZjdFgfrNjgsZnSdYGQjOBduZKVd9IJEZvj3eaubeuHWtMlL3-Hre1_7vleAe4tIM-1lRLc6mdCJxByOS8fShTCRxwmeOf1CKDwO7eEbeZ5Zsxq8V1oY1Sd0o5ojIqIWiPdcnderv0ssX9VWrh_4B059Pgax62uilIt1Ddvoav7AZZPIj6hGqUs9LZy6xfsc5iZ0D_YxiXYKLLBkUGhSVv8DSnACBxO0tcxPoSaXDTii1b9rDTgcl8_dOCyRt25Ck02fopdRyNo-Uq_Ei0cJez2Du4DFdKij-fmvJ3PqVfswz6GO_F62oN2zMISmtk1STkgmkIAISVKTG4J3-o7kF9DaZeVy99IVHP9UlhY1xtdQz7--5Q3Gz5zfKte3ScFykQ |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fT4MwEL7MaZxvumnmz-3B8EZko8D2QAwrINMBy0SyN0LXEn2Zi8P473sgqC97a9rkcm1yvft6910BbjUi1HSUEVkbZFwmAmM4JgxN5lxFHMdZZowLorAf6N4LeVxqywa81lyYsk_oV9kcES1qhfael_f15u8Ryy5rK7d37A2n3u_dyLQlXtHFhoquDCV7Yjrz0A6pRKlJLSlYmEV-DmMTugf7GGAbhS048aTgpGz-OxT3GA7mKGudn0BDrNvQovW_a2049Kt0Nw4ry9t2oOMsHsLZNHD6NkKv2IqmsfN8Cj3Xiagno_jkdycJtWo91DNoIr4XXeiPNHShqa6TlBGScQQgXJBUZQpng7Eh2Dl0d0m52L3Ug5YX-bMENXu6hKOfKtOi3vgKmvnHp7hGX5qzm_IYvgHSnXWE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ERGOLINE+DERIVATIVES&rft.inventor=FLUDZINSKI%2C+PAWEL&rft.inventor=GARBRECHT%2C+WILLIAM+L&rft.inventor=MARZONI%2C+GIFFORD+P&rft.date=1992-06-02&rft.externalDBID=C&rft.externalDocID=CA1302405C |